iodine has been researched along with Breast Neoplasms in 84 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although there is suggestive evidence for a preventive role for iodine and selenium in breast cancer, rigorous retrospective and prospective studies are needed to confirm this hypothesis." | 8.80 | Hypothesis: iodine, selenium and the development of breast cancer. ( Cann, SA; van Netten, C; van Netten, JP, 2000) |
| "Iodine has been suggested to protect against breast cancer, but there are no epidemiologic studies on individual risk." | 7.96 | Serum Iodine and Breast Cancer Risk: A Prospective Nested Case-Control Study Stratified for Selenium Levels. ( Borgquist, S; Manjer, J; Sandsveden, M, 2020) |
| "Objective To compare urinary iodine excretion levels in patients with breast cancer and control subjects." | 7.88 | The correlation between breast cancer and urinary iodine excretion levels. ( Dolay, K; Ersoy, YE; Guzel, M; Hasbahceci, M; Kadioglu, H; Malya, FU, 2018) |
| "The nonviral vector with iodine-nuclear localization sequence (namely, NLS-I) targeting breast cancer cells was fabricated." | 7.77 | Targeted delivery in breast cancer cells via iodine: nuclear localization sequence conjugate. ( Cheng, SX; Li, C; Sun, YX; Wang, HY; Yi, WJ; Zhang, XZ; Zhuo, RX, 2011) |
| "The protective effects of iodine on breast cancer have been postulated from epidemiologic evidence and described in animal models." | 7.74 | Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine. ( Brooks, AD; Eskin, BA; Johannes, GJ; Stoddard, FR, 2008) |
| "Hypothyroidism and low iodine intake may be important aetiological factors in oestrogen dependent tumours of the breast, uterus and ovary." | 7.67 | Di-iodothyronine as part of the oestradiol and catechol oestrogen receptor--the role of iodine, thyroid hormones and melatonin in the aetiology of breast cancer. ( Clur, A, 1988) |
| "The characteristics of different breast cancers imaged using dual-energy computed tomography (DECT) are unknown." | 5.91 | Dual-energy Computed Tomography Iodine Map for Breast Cancer: Comparison With Dynamic Contrast-enhanced Magnetic Resonance Imaging. ( Funakoshi, M; Goda, N; Kaneko, M; Mukaida, H; Ono, C, 2023) |
| "Patients with breast cancer clinical tumor categories 1 through 4 (cT1-4; tumor diameter <2 cm and up to >5 cm or extension to the chest wall or skin) and pathologically proven positive axillary lymph nodes (ie, clinical node categories cN1, metastases to movable ipsilateral level I and/or level II axillary nodes; cN2, metastases to fixed or matted ipsilateral level I and/or level II axillary nodes; cN3b, metastases to ipsilateral level I and/or level II axillary nodes with metastases to internal mammary nodes) who were treated with NAC were eligible for inclusion." | 5.72 | Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. ( Boskamp, M; Contant, CME; de Boer, M; Heijmans, HJ; Jager, A; Kam, BLR; Kelder, W; Koppert, LB; Lobbes, MBI; Luiten, EJT; Menke-Pluijmers, MBE; Sars, PRA; Simons, JM; Smidt, ML; Smit, LHM; van der Pol, CC; van Diest, PJ; van Haaren, ERM; van Klaveren, D; van Nijnatten, TJA; Verhoef, C; Vles, WJ, 2022) |
| "The detectability of breast cancer through mammography is rooted in the differential X-ray attenuation properties of cancerous and normal breast tissue." | 5.39 | The potential of iodine for improving breast cancer diagnosis and treatment. ( Altman, MB; Barton, KN; Brown, SL; Chetty, IJ; Flynn, MJ; Kim, JH; Movsas, B; Nishikawa, RM, 2013) |
| "Iodine deficiency is generally recognized as the most commonly preventable cause of mental retardation and the most common cause of endocrinopathy (goiter and primary hypothyroidism)." | 4.84 | Iodine: deficiency and therapeutic considerations. ( Patrick, L, 2008) |
| "Although there is suggestive evidence for a preventive role for iodine and selenium in breast cancer, rigorous retrospective and prospective studies are needed to confirm this hypothesis." | 4.80 | Hypothesis: iodine, selenium and the development of breast cancer. ( Cann, SA; van Netten, C; van Netten, JP, 2000) |
| "Iodine has been suggested to protect against breast cancer, but there are no epidemiologic studies on individual risk." | 3.96 | Serum Iodine and Breast Cancer Risk: A Prospective Nested Case-Control Study Stratified for Selenium Levels. ( Borgquist, S; Manjer, J; Sandsveden, M, 2020) |
| "Breast cancer remains a major concern and its physiopathology is influenced by iodine deficiency (ID) and radiation exposure." | 3.96 | Modulation of VEGF Expression and Oxidative Stress Response by Iodine Deficiency in Irradiated Cancerous and Non-Cancerous Breast Cells. ( Baselet, B; Ben Said, N; Buset, J; de Ville de Goyet, C; Derradji, H; Gérard, AC; Many, MC; Vanderstraeten, J, 2020) |
| "Objective To compare urinary iodine excretion levels in patients with breast cancer and control subjects." | 3.88 | The correlation between breast cancer and urinary iodine excretion levels. ( Dolay, K; Ersoy, YE; Guzel, M; Hasbahceci, M; Kadioglu, H; Malya, FU, 2018) |
| "FDS with iodine staining was superior to conventional FDS for the diagnosis of DIN and is valuable for breast cancer prevention." | 3.79 | Diagnostic accuracy of fiberoptic ductoscopy plus in vivo iodine staining for intraductal proliferative lesions. ( Feng, XZ; Jiang, CW; Mei, H; Song, YH; Zhang, FX; Zhao, B, 2013) |
| " Previously, we showed that molecular Iodine (I(2)) induces apoptosis in hormone responsive MCF-7 breast cancer cells, and non-apoptotic cell death in ER(-ve)-p53 mutant MDA-MB231 cells (Shrivastava, 2006)." | 3.77 | Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors. ( Agarwal, G; Annarao, S; Godbole, M; Ingle, A; Mitra, K; Rao, G; Roy, R; Singh, P; Tiwari, S, 2011) |
| "The nonviral vector with iodine-nuclear localization sequence (namely, NLS-I) targeting breast cancer cells was fabricated." | 3.77 | Targeted delivery in breast cancer cells via iodine: nuclear localization sequence conjugate. ( Cheng, SX; Li, C; Sun, YX; Wang, HY; Yi, WJ; Zhang, XZ; Zhuo, RX, 2011) |
| " In the human breast cancer cell line MCF-7, I(2) treatment generates iodine-containing lipids similar to 6-iodo-5-hydroxy-eicosatrienoic acid and the 6-iodolactone (6-IL) derivative of arachidonic acid (AA), and it significantly decreases cellular proliferation and induces caspase-dependent apoptosis." | 3.75 | A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer. ( Aceves, C; Arroyo-Helguera, O; Cajero-Juárez, M; López-Bojorquez, L; Nuñez-Anita, RE, 2009) |
| "The protective effects of iodine on breast cancer have been postulated from epidemiologic evidence and described in animal models." | 3.74 | Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine. ( Brooks, AD; Eskin, BA; Johannes, GJ; Stoddard, FR, 2008) |
| "To investigate the chemopreventive effects of seaweed on breast cancer, we have been studying the relationship between iodine and breast cancer." | 3.71 | Seaweed prevents breast cancer? ( Funahashi, H; Hayakawa, A; Hayashi, H; Hayashi, T; Hibi, Y; Imai, T; Mase, T; Mizuno, Y; Nishikawa, M; Sekiya, M; Shibata, A; Suda, N; Tanuma, S; Tsukamura, K; Yokoi, K, 2001) |
| "Hypothyroidism and low iodine intake may be important aetiological factors in oestrogen dependent tumours of the breast, uterus and ovary." | 3.67 | Di-iodothyronine as part of the oestradiol and catechol oestrogen receptor--the role of iodine, thyroid hormones and melatonin in the aetiology of breast cancer. ( Clur, A, 1988) |
| "We recruited women with primary breast cancer following primary treatment with seven or more HFNS/week (including 4/10 or above on the HFNS problem rating scale), from six UK hospitals to an open, randomised, phase 3 effectiveness trial." | 2.94 | Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: Results of the MENOS4 randomised controlled trial. ( Day, L; Ellis, M; Fenlon, D; Fields, J; Griffiths, G; Hunter, MS; Maishman, T; May, C; Nuttall, J; Raftery, J; Turner, L, 2020) |
| " As to intermittent maintance treatment the total dosage of seaweed herb was at least exceeded 500 gram." | 2.49 | Induction of thyroid neoplasm following plant medicine marine algae (sargassum): a rare case and review of the literature. ( Byrne, P; Musumeci, F; Zhu, G, 2013) |
| "Thyroid carcinomas are the most frequent endocrine malignancies." | 2.41 | Iodine and cancer. ( Feldt-Rasmussen, U, 2001) |
| "The characteristics of different breast cancers imaged using dual-energy computed tomography (DECT) are unknown." | 1.91 | Dual-energy Computed Tomography Iodine Map for Breast Cancer: Comparison With Dynamic Contrast-enhanced Magnetic Resonance Imaging. ( Funakoshi, M; Goda, N; Kaneko, M; Mukaida, H; Ono, C, 2023) |
| "All patients at the University Breast Cancer Center who underwent a clinically indicated DLCT-scan and a breast MRI for staging of invasive ductal breast cancer from 2016 to 2020 were prospectively included." | 1.91 | Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas. ( Barbara Krug, K; Campbell, GM; Gabriel Schafigh, D; Hellmich, M; Klein, K; Maintz, D; Malter, W; Schömig-Markiefka, B; Weiss, K, 2023) |
| "Patients with breast cancer clinical tumor categories 1 through 4 (cT1-4; tumor diameter <2 cm and up to >5 cm or extension to the chest wall or skin) and pathologically proven positive axillary lymph nodes (ie, clinical node categories cN1, metastases to movable ipsilateral level I and/or level II axillary nodes; cN2, metastases to fixed or matted ipsilateral level I and/or level II axillary nodes; cN3b, metastases to ipsilateral level I and/or level II axillary nodes with metastases to internal mammary nodes) who were treated with NAC were eligible for inclusion." | 1.72 | Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. ( Boskamp, M; Contant, CME; de Boer, M; Heijmans, HJ; Jager, A; Kam, BLR; Kelder, W; Koppert, LB; Lobbes, MBI; Luiten, EJT; Menke-Pluijmers, MBE; Sars, PRA; Simons, JM; Smidt, ML; Smit, LHM; van der Pol, CC; van Diest, PJ; van Haaren, ERM; van Klaveren, D; van Nijnatten, TJA; Verhoef, C; Vles, WJ, 2022) |
| "In the present study, wild-type breast carcinoma cells (MCF-7/W) were treated chronically with 10 nM doxorubicin (DOX) to establish a low-dose DOX-resistant mammary cancer model (MCF-7/D)." | 1.46 | Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin. ( Aceves, C; Bontempo, A; Delgado-González, E; Rodríguez, ÁL; Ugalde-Villanueva, B, 2017) |
| "452 patients with breast cancer underwent a 99mTc methylene diphosphonate (MDP) bone scan for surveillance of bone metastasis." | 1.43 | Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast. ( Cho, YS; Choe, YS; Choi, JY; Hyun, SH; Kim, BT; Kim, SJ; Lee, JH; Lee, KH; Moon, SH, 2016) |
| "The detectability of breast cancer through mammography is rooted in the differential X-ray attenuation properties of cancerous and normal breast tissue." | 1.39 | The potential of iodine for improving breast cancer diagnosis and treatment. ( Altman, MB; Barton, KN; Brown, SL; Chetty, IJ; Flynn, MJ; Kim, JH; Movsas, B; Nishikawa, RM, 2013) |
| "Iodine treatment induces the translocation of apoptosis-inducing factor from mitochondria to the nucleus, and treatment of N-acetyl-L-cysteine prior to iodine exposure restored basal thiol content, ROS levels, and completely inhibited nuclear translocation of apoptosis-inducing factor and subsequently cell death, indicating that thiol depletion may play an important role in iodine-induced cell death." | 1.33 | Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. ( Bajpai, VK; Balapure, AK; Godbole, MM; Kumar, A; Mitra, K; Sharma, R; Shrivastava, A; Sinha, RA; Tandon, A; Tiwari, M, 2006) |
| "Among eight breast cancer cell lines, three out of four estrogen receptor (ER)-positive and zero of four ER-negative cell lines responded to 9-cis RA by increasing their expression of NIS." | 1.32 | Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. ( Akashi, M; Dan, K; Heaney, A; Ikezoe, T; Koeffler, HP; Said, JW; Tanosaki, S, 2003) |
| "Development of breast tumors is often accompanied by angiogenesis--the formation of new blood vessels." | 1.31 | Development of contrast digital mammography. ( Bloomquist, AK; Jeunehomme, F; Muller, S; Rick, A; Rico, D; Skarpathiotakis, M; Yaffe, MJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (30.95) | 18.7374 |
| 1990's | 4 (4.76) | 18.2507 |
| 2000's | 21 (25.00) | 29.6817 |
| 2010's | 18 (21.43) | 24.3611 |
| 2020's | 15 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Coufal, O | 1 |
| Schneiderová, M | 1 |
| Fabian, P | 1 |
| Kozáková, Š | 1 |
| Řehák, Z | 1 |
| Bártl, J | 1 |
| Bartlová, R | 1 |
| Glatzner, M | 1 |
| Zapletal, O | 1 |
| Gabrielová, L | 1 |
| Amir, T | 1 |
| Hogan, MP | 1 |
| Jacobs, S | 1 |
| Sevilimedu, V | 1 |
| Sung, J | 1 |
| Jochelson, MS | 1 |
| Lin, GH | 1 |
| Chen, WY | 1 |
| Chen, CM | 1 |
| Cheng, X | 1 |
| Zhou, BH | 1 |
| Ji, JS | 1 |
| Simons, JM | 1 |
| van Nijnatten, TJA | 1 |
| van der Pol, CC | 1 |
| van Diest, PJ | 1 |
| Jager, A | 1 |
| van Klaveren, D | 1 |
| Kam, BLR | 1 |
| Lobbes, MBI | 1 |
| de Boer, M | 1 |
| Verhoef, C | 1 |
| Sars, PRA | 1 |
| Heijmans, HJ | 1 |
| van Haaren, ERM | 1 |
| Vles, WJ | 1 |
| Contant, CME | 1 |
| Menke-Pluijmers, MBE | 1 |
| Smit, LHM | 1 |
| Kelder, W | 1 |
| Boskamp, M | 1 |
| Koppert, LB | 1 |
| Luiten, EJT | 1 |
| Smidt, ML | 1 |
| Pötsch, N | 1 |
| Vatteroni, G | 1 |
| Clauser, P | 1 |
| Helbich, TH | 1 |
| Baltzer, PAT | 1 |
| Klein, K | 1 |
| Gabriel Schafigh, D | 1 |
| Schömig-Markiefka, B | 1 |
| Campbell, GM | 1 |
| Weiss, K | 1 |
| Malter, W | 1 |
| Maintz, D | 1 |
| Hellmich, M | 1 |
| Barbara Krug, K | 1 |
| Munck, F | 1 |
| Jepsen, P | 1 |
| Zeuthen, P | 1 |
| Carstensen, L | 1 |
| Hauerslev, K | 1 |
| Paaskesen, CK | 1 |
| Andersen, IS | 1 |
| Høyer, U | 1 |
| Lanng, C | 1 |
| Gerlach, MK | 1 |
| Vejborg, I | 1 |
| Kroman, NT | 1 |
| Tvedskov, THF | 1 |
| Goda, N | 1 |
| Funakoshi, M | 1 |
| Ono, C | 1 |
| Mukaida, H | 1 |
| Kaneko, M | 1 |
| Peña, M | 1 |
| Delgado-Gonzalez, E | 3 |
| López-Marín, LM | 1 |
| Millán-Chiu, BE | 1 |
| Fernández, F | 1 |
| Rodriguez-Castelan, J | 1 |
| Muñoz-Torres, C | 1 |
| Carrasco, G | 1 |
| Anguiano, B | 3 |
| Loske, AM | 1 |
| Aceves, C | 8 |
| Manjer, J | 1 |
| Sandsveden, M | 1 |
| Borgquist, S | 1 |
| Vanderstraeten, J | 1 |
| Baselet, B | 1 |
| Buset, J | 1 |
| Ben Said, N | 1 |
| de Ville de Goyet, C | 1 |
| Many, MC | 1 |
| Gérard, AC | 1 |
| Derradji, H | 1 |
| Cuenca-Micó, O | 1 |
| Wang, X | 1 |
| Liu, D | 1 |
| Zeng, X | 1 |
| Jiang, S | 1 |
| Li, L | 1 |
| Yu, T | 1 |
| Zhang, J | 1 |
| Malya, FU | 1 |
| Kadioglu, H | 1 |
| Hasbahceci, M | 1 |
| Dolay, K | 1 |
| Guzel, M | 1 |
| Ersoy, YE | 1 |
| Bontempo, A | 1 |
| Ugalde-Villanueva, B | 1 |
| Rodríguez, ÁL | 1 |
| Song, W | 1 |
| Liu, QS | 1 |
| Sun, Z | 1 |
| Yang, X | 1 |
| Zhou, Q | 1 |
| Jiang, G | 1 |
| Mendieta, I | 1 |
| Nuñez-Anita, RE | 3 |
| Nava-Villalba, M | 1 |
| Zambrano-Estrada, X | 1 |
| Khan, AJ | 1 |
| Feng, XZ | 1 |
| Song, YH | 1 |
| Zhang, FX | 1 |
| Jiang, CW | 1 |
| Mei, H | 1 |
| Zhao, B | 1 |
| Zhu, G | 1 |
| Musumeci, F | 1 |
| Byrne, P | 1 |
| Karunamuni, R | 1 |
| Tsourkas, A | 1 |
| Maidment, AD | 1 |
| Kim, SJ | 1 |
| Choi, JY | 1 |
| Lee, JH | 1 |
| Hyun, SH | 1 |
| Cho, YS | 1 |
| Moon, SH | 1 |
| Choe, YS | 1 |
| Lee, KH | 1 |
| Kim, BT | 1 |
| Cong, BB | 1 |
| Qiu, PF | 1 |
| Liu, YB | 1 |
| Zhao, T | 1 |
| Chen, P | 1 |
| Cao, XS | 1 |
| Wang, CJ | 1 |
| Zhang, ZP | 1 |
| Sun, X | 1 |
| Yu, JM | 1 |
| Wang, YS | 1 |
| Patrick, L | 1 |
| Stoddard, FR | 1 |
| Brooks, AD | 1 |
| Eskin, BA | 6 |
| Johannes, GJ | 1 |
| Arroyo-Helguera, O | 2 |
| Rojas, E | 1 |
| Delgado, G | 2 |
| Cajero-Juárez, M | 2 |
| López-Bojorquez, L | 1 |
| Wang, HY | 1 |
| Li, C | 1 |
| Yi, WJ | 1 |
| Sun, YX | 1 |
| Cheng, SX | 1 |
| Zhuo, RX | 1 |
| Zhang, XZ | 1 |
| Singh, P | 1 |
| Godbole, M | 1 |
| Rao, G | 1 |
| Annarao, S | 1 |
| Mitra, K | 2 |
| Roy, R | 1 |
| Ingle, A | 1 |
| Agarwal, G | 2 |
| Tiwari, S | 1 |
| Kogai, T | 1 |
| Liu, YY | 1 |
| Mody, K | 1 |
| Shamsian, DV | 1 |
| Brent, GA | 1 |
| Neto, C | 1 |
| Oliveira, MC | 1 |
| Gano, L | 1 |
| Marques, F | 1 |
| Yasuda, T | 1 |
| Thiemann, T | 1 |
| Kniess, T | 1 |
| Santos, I | 1 |
| Altman, MB | 1 |
| Flynn, MJ | 1 |
| Nishikawa, RM | 1 |
| Chetty, IJ | 1 |
| Barton, KN | 1 |
| Movsas, B | 1 |
| Kim, JH | 1 |
| Brown, SL | 1 |
| Chung, JK | 1 |
| Spitzweg, C | 1 |
| Morris, JC | 1 |
| Skarpathiotakis, M | 1 |
| Yaffe, MJ | 1 |
| Bloomquist, AK | 1 |
| Rico, D | 1 |
| Muller, S | 2 |
| Rick, A | 1 |
| Jeunehomme, F | 2 |
| Upadhyay, G | 1 |
| Singh, R | 1 |
| Mishra, SK | 1 |
| Pal, L | 1 |
| Pradhan, PK | 1 |
| Das, BK | 1 |
| Godbole, MM | 2 |
| Tanosaki, S | 1 |
| Ikezoe, T | 1 |
| Heaney, A | 1 |
| Said, JW | 1 |
| Dan, K | 1 |
| Akashi, M | 1 |
| Koeffler, HP | 1 |
| Smyth, PP | 3 |
| ROCCAVILLA, G | 1 |
| CARRETTI, D | 1 |
| CARBONARA, P | 1 |
| ARATA, L | 1 |
| PECORA, P | 1 |
| CARTER, AC | 1 |
| FELDMAN, EB | 1 |
| SCHWARTZ, HL | 1 |
| COREY, KR | 2 |
| GROSS, J | 2 |
| VOLKOVA, MA | 1 |
| LAZAREV, NI | 1 |
| IRD, EA | 1 |
| YANISHEVSKY, VI | 1 |
| VISHNJAKOVA, EG | 1 |
| MANUILOVA, IA | 1 |
| ROTENBERG, AD | 1 |
| BRUCE, WR | 1 |
| BAKER, RG | 1 |
| Torremante, P | 1 |
| Diekmann, F | 1 |
| Diekmann, S | 1 |
| Hamm, B | 1 |
| Bick, U | 1 |
| Bezpalov, VG | 1 |
| Barash, NIu | 1 |
| Ivanova, OA | 1 |
| Semënov, II | 1 |
| Aleksandrov, VA | 1 |
| Semiglazov, VF | 1 |
| Shrivastava, A | 1 |
| Tiwari, M | 1 |
| Sinha, RA | 1 |
| Kumar, A | 1 |
| Balapure, AK | 1 |
| Bajpai, VK | 1 |
| Sharma, R | 1 |
| Tandon, A | 1 |
| Saito, M | 1 |
| Bartuska, DG | 1 |
| Dunn, MR | 1 |
| Jacob, G | 1 |
| Dratman, MB | 1 |
| Apffelstaedt, JP | 1 |
| Van Zyl, JA | 1 |
| Muller, AG | 1 |
| Foster, HD | 1 |
| Smith, DF | 1 |
| McDermott, EW | 2 |
| Murray, MJ | 1 |
| Geraghty, JG | 1 |
| O'Higgins, NJ | 2 |
| Hussain, S | 1 |
| Lui, DM | 1 |
| Cann, SA | 1 |
| van Netten, JP | 1 |
| van Netten, C | 1 |
| Kilbane, MT | 1 |
| Ajjan, RA | 1 |
| Weetman, AP | 1 |
| Dwyer, R | 1 |
| Funahashi, H | 1 |
| Imai, T | 1 |
| Mase, T | 1 |
| Sekiya, M | 1 |
| Yokoi, K | 1 |
| Hayashi, H | 1 |
| Shibata, A | 1 |
| Hayashi, T | 1 |
| Nishikawa, M | 1 |
| Suda, N | 1 |
| Hibi, Y | 1 |
| Mizuno, Y | 1 |
| Tsukamura, K | 1 |
| Hayakawa, A | 1 |
| Tanuma, S | 1 |
| Feldt-Rasmussen, U | 1 |
| Tokudome, S | 1 |
| Kuriki, K | 1 |
| Moore, MA | 1 |
| Stadel, BV | 1 |
| Sidorenko, LN | 2 |
| Egor'kova, AS | 1 |
| Carroll, KK | 1 |
| Clur, A | 1 |
| Serra Majem, LL | 1 |
| Tresserras, R | 1 |
| Canela, J | 1 |
| Salleras, L | 1 |
| Balybin, ES | 2 |
| Palinkashi, DG | 2 |
| Shal'neva, TS | 1 |
| Parker, JA | 1 |
| Bassett, JG | 1 |
| George, DL | 1 |
| Stephens, FO | 1 |
| Lawrenson, KB | 1 |
| Chant, S | 1 |
| Stewart, HJ | 1 |
| Benson, EA | 1 |
| Roberts, MM | 1 |
| Forrest, AP | 1 |
| Greenwood, FC | 1 |
| Jones, GR | 1 |
| de Valois, B | 1 |
| Young, T | 1 |
| Thorpe, P | 1 |
| Degun, T | 1 |
| Corbishley, K | 1 |
| Fenlon, D | 1 |
| Maishman, T | 1 |
| Day, L | 1 |
| Nuttall, J | 1 |
| May, C | 1 |
| Ellis, M | 1 |
| Raftery, J | 1 |
| Turner, L | 1 |
| Fields, J | 1 |
| Griffiths, G | 1 |
| Hunter, MS | 1 |
| Lyon, AR | 1 |
| Habibian, M | 1 |
| Horn, TD | 1 |
| Beveridge, RA | 1 |
| Egorin, MJ | 1 |
| Abeloff, MD | 1 |
| Hood, AF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dietary Iodine Supplementation on the Proliferation of Breast Cancer[NCT03688958] | Phase 2 | 120 participants (Anticipated) | Interventional | 2005-03-15 | Recruiting | ||
| Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study[NCT01433640] | 30 participants (Actual) | Observational | 2011-07-31 | Completed | |||
| A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen™ for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease[NCT00237523] | Phase 3 | 175 participants (Anticipated) | Interventional | 2005-07-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for iodine and Breast Neoplasms
| Article | Year |
|---|---|
Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
Topics: Breast; Breast Neoplasms; Contrast Media; Female; Humans; Iodine; Magnetic Resonance Imaging; Mammog | 2022 |
Micronutrients and Breast Cancer Progression: A Systematic Review.
Topics: Breast Neoplasms; Female; Humans; Iodine; Micronutrients; Trace Elements; Vitamin D | 2020 |
Induction of thyroid neoplasm following plant medicine marine algae (sargassum): a rare case and review of the literature.
Topics: Adult; Breast Neoplasms; Female; Humans; Iodine; Medicine, Traditional; Plant Preparations; Sargassu | 2013 |
Iodine: deficiency and therapeutic considerations.
Topics: Animals; Breast Neoplasms; Developed Countries; Fibrocystic Breast Disease; Goiter, Endemic; Humans; | 2008 |
Iodine. Monograph.
Topics: Animals; Breast Neoplasms; Clinical Trials as Topic; Dietary Supplements; Dose-Response Relationship | 2010 |
Peroxisome proliferator-activated receptors: role of isoform gamma in the antineoplastic effect of iodine in mammary cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Iodine; Peroxisome Proliferator-Activated R | 2011 |
Sodium iodide symporter: its role in nuclear medicine.
Topics: Animals; Breast Neoplasms; Congenital Hypothyroidism; Female; Gene Expression; Gene Targeting; Genes | 2002 |
The sodium iodide symporter: its pathophysiological and therapeutic implications.
Topics: Biological Transport, Active; Breast; Breast Neoplasms; Carcinoma, Papillary; Carcinoma, Papillary, | 2002 |
The thyroid, iodine and breast cancer.
Topics: Animals; Breast Neoplasms; Female; Humans; Iodine; Risk Factors; Thyroid Diseases | 2003 |
[Mastopathy, breast cancer and iodolactone].
Topics: Animals; Arachidonic Acid; Breast Neoplasms; Female; Fibrocystic Breast Disease; Fish Oils; Fishes; | 2004 |
Is iodine a gatekeeper of the integrity of the mammary gland?
Topics: Antioxidants; Breast Neoplasms; Female; Humans; Iodine; Mammary Glands, Human; Risk Factors | 2005 |
Breast cancer complicated by pleural effusion: patient characteristics and results of surgical management.
Topics: Breast Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Female; Humans; Iodine; Male; M | 1995 |
Hypothesis: iodine, selenium and the development of breast cancer.
Topics: Animals; Breast Neoplasms; Confidence Intervals; Drug Interactions; Female; Humans; Incidence; Iodin | 2000 |
Iodine and cancer.
Topics: Animals; Breast Neoplasms; Diagnosis, Differential; Diet; Disease Models, Animal; Humans; Iodine; Th | 2001 |
Experimental evidence of dietary factors and hormone-dependent cancers.
Topics: Animal Feed; Animals; Breast Neoplasms; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; | 1975 |
4 trials available for iodine and Breast Neoplasms
| Article | Year |
|---|---|
[Investigation of the drug "Mamoclam" for the treatment of patients with fibroadenomatosis of the breast].
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chlorophyll; Drug Administration Schedule; Fatty Aci | 2005 |
Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer.
Topics: Animals; Antibodies; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Carrier Proteins; CHO Cel | 2000 |
Iodine and mammary cancer.
Topics: Animals; Breast; Breast Neoplasms; Clinical Trials as Topic; Cocarcinogenesis; Female; Humans; Iodin | 1977 |
Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: Results of the MENOS4 randomised controlled trial.
Topics: Adult; Aged; Anxiety; Breast Neoplasms; Cognitive Behavioral Therapy; Depression; Female; Hot Flashe | 2020 |
65 other studies available for iodine and Breast Neoplasms
| Article | Year |
|---|---|
Iodine seed localisation of non-palpable lesions in breast surgery first experience.
Topics: Breast Neoplasms; Female; Humans; Iodine; Iodine Radioisotopes; Mastectomy; Mastectomy, Segmental; T | 2021 |
Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography.
Topics: Breast Neoplasms; Contrast Media; Female; Humans; Iodine; Mammography; Middle Aged; Radiographic Ima | 2022 |
[Construction of prediction model combined dual-energy CT quantitative parameters and conventional CT features for assessing the Ki-67 expression levels in invasive breast cancer].
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Humans; Iodine; Ki-67 Antigen; Male; Retrospectiv | 2022 |
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Node Excision; Lymph N | 2022 |
Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas.
Topics: Biomarkers; Breast Neoplasms; Female; Humans; Iodine; Magnetic Resonance Imaging; Tomography, X-Ray | 2023 |
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study.
Topics: Axilla; Breast Neoplasms; Female; Humans; Iodine; Lymph Node Excision; Lymph Nodes; Lymphadenopathy; | 2023 |
Dual-energy Computed Tomography Iodine Map for Breast Cancer: Comparison With Dynamic Contrast-enhanced Magnetic Resonance Imaging.
Topics: Breast Neoplasms; Carcinoma; Female; Humans; Iodine; Magnetic Resonance Imaging; Receptors, Estrogen | 2023 |
Shock Wave Application Increases the Antineoplastic Effect of Molecular Iodine Supplement in Breast Cancer Xenografts.
Topics: Animals; Breast Neoplasms; Combined Modality Therapy; Female; Heterografts; High-Energy Shock Waves; | 2020 |
Serum Iodine and Breast Cancer Risk: A Prospective Nested Case-Control Study Stratified for Selenium Levels.
Topics: Breast Neoplasms; Case-Control Studies; Female; Humans; Iodine; Risk Factors; Selenium | 2020 |
Modulation of VEGF Expression and Oxidative Stress Response by Iodine Deficiency in Irradiated Cancerous and Non-Cancerous Breast Cells.
Topics: Antioxidants; Breast; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; | 2020 |
Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Immunohis | 2021 |
The correlation between breast cancer and urinary iodine excretion levels.
Topics: Adult; Biomarkers, Tumor; Blood Urea Nitrogen; Breast Neoplasms; Case-Control Studies; Creatinine; F | 2018 |
Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
Topics: Animals; Antigens, CD; Biomarkers, Tumor; Breast Neoplasms; Cadherins; CD24 Antigen; Cell Proliferat | 2017 |
Polyfluorinated iodine alkanes regulated distinct breast cancer cell progression through binding with estrogen receptor alpha or beta isoforms.
Topics: Alkanes; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Estradiol; | 2018 |
Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Movement; Cell Pr | 2019 |
In Reply to Yadav and Gupta, and Hannoun-Levi et al.
Topics: Brachytherapy; Breast; Breast Neoplasms; Humans; Iodine | 2019 |
Diagnostic accuracy of fiberoptic ductoscopy plus in vivo iodine staining for intraductal proliferative lesions.
Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltr | 2013 |
Exploring silver as a contrast agent for contrast-enhanced dual-energy X-ray breast imaging.
Topics: Algorithms; Breast; Breast Neoplasms; Contrast Media; Humans; Iodine; Mammography; Models, Theoretic | 2014 |
Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Incidental Findings; Injections, Intravenous; Iodi | 2016 |
Validation study for the hypothesis of internal mammary sentinel lymph node lymphatic drainage in breast cancer.
Topics: Adult; Aged; Axilla; Biopsy; Breast Neoplasms; Female; Fluorescent Dyes; Humans; Indocyanine Green; | 2016 |
Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine.
Topics: 20-Hydroxysteroid Dehydrogenases; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Cell Cycle; Cell | 2008 |
Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects.
Topics: Apoptosis; Apoptosis Inducing Factor; Arachidonic Acid; Breast; Breast Neoplasms; Caspases; Cell Cyc | 2008 |
A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
Topics: Animals; Antineoplastic Agents; Arachidonic Acid; Arachidonic Acids; Breast Neoplasms; Cell Line, Tu | 2009 |
Targeted delivery in breast cancer cells via iodine: nuclear localization sequence conjugate.
Topics: Active Transport, Cell Nucleus; Breast Neoplasms; Cell Line, Tumor; DNA; Female; Genetic Therapy; Hu | 2011 |
Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Caspase 3; Caspase 9; Cathep | 2011 |
Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulati | 2012 |
Novel 7α-alkoxy-17α-(4'-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: synthesis and binding affinity evaluation.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Female; Fluorine; Humans; Iodine; Magnetic Res | 2012 |
The potential of iodine for improving breast cancer diagnosis and treatment.
Topics: Breast Neoplasms; Contrast Media; Female; Humans; Iodine; Models, Biological; Symporters | 2013 |
Development of contrast digital mammography.
Topics: Algorithms; Breast Neoplasms; Contrast Media; Copper; Female; Humans; Iodine; Mammography; Molybdenu | 2002 |
Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
Topics: Adult; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Immunohistoch | 2003 |
Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Iodine; Iodine Radioisotopes; Ligands; Neop | 2003 |
[Influence of bilateral ovariectomy on protein-bound iodine in blood].
Topics: Breast; Breast Neoplasms; Castration; Female; Humans; Iodine; Mastectomy; Ovariectomy | 1958 |
[Research on the protein-bound iodine of the circulating blood. V. Behavior of the blood proteinbound iodine in women with cancer of the breast and of the uterus].
Topics: Breast; Breast Neoplasms; Female; Humans; Iodine; Neoplasms; Uterine Neoplasms | 1959 |
Levels of serum protein-bound iodine in patients with metastatic carcinoma of the breast.
Topics: Blood Proteins; Breast; Breast Neoplasms; Humans; Iodine | 1960 |
Labeled iodinated compounds in tumors and tissues of C3H mice after the injection of I 131-labeled triiodothyronine.
Topics: Animals; Breast Neoplasms; Humans; Iodine; Iodine Radioisotopes; Mice; Mice, Inbred C3H; Neoplasms; | 1960 |
The concentration of radioactive triiodothyronine in mammary tumors and tissues of C3H mice.
Topics: Animals; Breast Neoplasms; Humans; Iodine; Iodine Radioisotopes; Mammary Neoplasms, Animal; Mice; Mi | 1960 |
[Administration of radioactive gold colloid and radioactive iodine at the P. A. Herzen State Oncological Institute].
Topics: Breast Neoplasms; Female; Gold Colloid; Gold Colloid, Radioactive; Humans; Iodine; Iodine Isotopes; | 1962 |
THEORETICAL VALIDITY AND PRELIMINARY RESULTS OF IODINE THERAPY OF MASTOPATHY.
Topics: Animals; Breast Neoplasms; Chorionic Gonadotropin; Cysts; Female; Gonadotropins; Humans; Iodides; Io | 1964 |
Incorporation of 5-iododeoxyuridine 1311 in spontaneous C3H mouse mammary tumours.
Topics: Animals; Breast Neoplasms; Humans; Idoxuridine; Iodine; Iodine Radioisotopes; Mice; Mice, Inbred C3H | 1962 |
Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement.
Topics: Animals; Breast Neoplasms; Contrast Media; Female; Humans; Iodine; Magnetic Resonance Imaging; Mammo | 2005 |
Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway.
Topics: Antioxidants; Apoptosis; Apoptosis Inducing Factor; Breast Neoplasms; Caspases; Cell Line, Tumor; Cy | 2006 |
Dual-energy approach to contrast-enhanced mammography using the balanced filter method: spectral optimization and preliminary phantom measurement.
Topics: Breast; Breast Neoplasms; Contrast Media; Equipment Design; Female; Humans; Iodine; Mammography; Neo | 2007 |
Mammary gland dysplasia in iodine deficiency. Studies in rats.
Topics: Animals; Breast Neoplasms; Estrogens; Female; Histocytochemistry; Hypothyroidism; Iodine; Mammary Gl | 1967 |
The iodine-selenium connection: its possible roles in intelligence, cretinism, sudden infant death syndrome, breast cancer and multiple sclerosis.
Topics: Breast Neoplasms; Congenital Hypothyroidism; Female; Humans; Infant; Intelligence; Iodine; Models, B | 1993 |
A direct relationship between thyroid enlargement and breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Female; Humans; Iodine; Middle Ag | 1996 |
Ultrasound guided percutaneous galactography.
Topics: Adult; Biopsy, Needle; Breast; Breast Neoplasms; Contrast Media; Female; Humans; Iodine; Mammography | 1997 |
Seaweed prevents breast cancer?
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Breast Neoplasms; Culture Media; Humans; Iodin | 2001 |
Seaweed and cancer prevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Dietary Fiber; Female; | 2001 |
Dietary iodine and risk of breast, endometrial, and ovarian cancer.
Topics: Breast Neoplasms; Diet; Endometriosis; Estrogens; Female; Gonadotropins; Humans; Hypothyroidism; Iod | 1976 |
Dietary iodine and cancer risk.
Topics: Breast Neoplasms; Female; Humans; Iodine; Risk | 1976 |
[Protein bound iodine indices in patients with mastopathy].
Topics: Adenofibroma; Blood Proteins; Breast Neoplasms; Female; Humans; Iodine; Mental Disorders; Protein Bi | 1978 |
Di-iodothyronine as part of the oestradiol and catechol oestrogen receptor--the role of iodine, thyroid hormones and melatonin in the aetiology of breast cancer.
Topics: Breast Neoplasms; Diiodothyronines; Dopamine; Female; Humans; Hypothyroidism; Iodine; Melatonin; Mod | 1988 |
Dietary iodine deficiency and breast cancer mortality: an ecological study.
Topics: Adult; Breast Neoplasms; Diet; Ecology; Female; Humans; Iodine; Spain | 1988 |
[The state of iodine metabolism following gamma therapy of oncologic patients].
Topics: Adult; Aged; Breast Neoplasms; Esophageal Neoplasms; Female; Humans; Iodine; Iodine Isotopes; Lung N | 1972 |
[The significance of the state of iodine metabolism in the development of general radiation reactions].
Topics: Adult; Aged; Breast Neoplasms; Esophageal Neoplasms; Female; Humans; Iodine; Iodine Isotopes; Lung N | 1972 |
[Therapy of diffuse dyshormonal hyperplasia of the breasts].
Topics: Adenofibroma; Adenoma; Adult; Androgens; Breast Neoplasms; Female; Humans; Hyperplasia; Hypnotics an | 1973 |
Editorial: The thyroid and breast cancer.
Topics: Breast Neoplasms; Estrogens; Female; Humans; Hypothyroidism; Iodine; Prognosis; Prolactin; Thyroid N | 1974 |
Human breast uptake of radioactive iodine.
Topics: Adenofibroma; Adult; Biopsy; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Female; Humans; I | 1974 |
The use of iodized catgut and electrocoagulation diathermy in relation to the incidence of tumour recurrence in operation wounds: An experimental study.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Line; Electrocoagulation; Female; Iodine; Melanoma; Mice; | 1970 |
Iodine metabolism and breast cancer.
Topics: Animals; Anthracenes; Breast; Breast Diseases; Breast Neoplasms; Deficiency Diseases; Demography; Es | 1970 |
Pituitary function after yttrium implants as measured by plasma growth hormone levels.
Topics: Blood Glucose; Blood Proteins; Breast Neoplasms; Cholesterol; Female; Growth Hormone; Humans; Hydroc | 1971 |
Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis.
Topics: Adult; Breast Neoplasms; Drainage; Female; Humans; Iodine; Lung Neoplasms; Middle Aged; Pleura; Pleu | 1969 |
Acupuncture in the real world: evaluating a 15-year NADA auricular acupuncture service for breast cancer survivors experiencing hot flushes and night sweats as a consequence of adjuvant hormonal therapies.
Topics: Acupuncture Therapy; Acupuncture, Ear; Breast Neoplasms; Cancer Survivors; Female; Hot Flashes; Huma | 2022 |
Break a sweat to reduce cardiotoxicity - the benefits of exercise training during anthracycline chemotherapy.
Topics: Anthracyclines; Breast Neoplasms; Cardiotoxicity; Exercise; Humans; Sweat | 2019 |
Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1989 |